Quick search:
Content Search
Result Content Research
Result Content Research
1 Will Arvinas Stock Rebound After A 12% Drop In A Month?
2 Is Arvinas, Inc. (ARVN) Going to Burn These Hedge Funds?
3 Arvinas Inc Ranked Among Today’s Top Shorts As 10-Year Bond Yields Spike
4 Should Biotechnology Stock Arvinas Inc (ARVN) Be in Your Portfolio Tuesday?
5 Arvinas Inc Ranked Among Today’s Top Shorts As U.S. Deals With A Debt Ceiling Crisis
6 Analyst Ratings For Arvinas
7 Arvinas Inc (ARVN) Stock Declines -2.72% This Week; Should You Buy?
8 Arvinas (ARVN) falls 3.33% to Close at $82.27 on October 18
9 Research Analysts Issue Forecasts for Arvinas, Inc.'s Q3 2021 Earnings (NASDAQ:ARVN)
10 Arvinas (ARVN) falls 3.04% on Moderate Volume October 15
11 Arvinas (NASDAQ:ARVN) Coverage Initiated at Stifel Nicolaus
12 What Fuels the Northeast's Life Sciences Industry
13 Novel protein degrader against 'undruggable' cancer target inhibits tumors in mice
14 Arvinas (NASDAQ:ARVN) Earns Outperform Rating from Analysts at SVB Leerink
15 Regents Of The University Of California Buys ironSource, Alibaba Group Holding, Sana Biotechnology Inc, Sells , Upstart Holdings Inc, RAPT Therapeutics Inc
16 Radius Health price target raised on Wall Street after trial win for breast cancer drug
17 Pfizer funnels $1B into protein degrader Arvinas, with more in biobucks on the table
18 10 Earnings Reports Everyone is Talking About
19 Arvinas to Participate in Upcoming Virtual Investor Conferences
20 Arvinas Reports Second Quarter 2021 Financial Results and Provides Corporate Update
21 Arvinas Signs Lease for New Space Within Downtown Crossing
22 Arvinas unveils PROTAC structures
23 Pfizer pays $1 billion to develop Arvinas protein degrader
24 Arvinas Participates in Groundbreaking Ceremony for New Space Within Downtown Crossing Development in New Haven
25 Down Over 20% In A Month Can Arvinas Stock Rebound?
26 Expansion raises $80M to develop drugs for neurodegenerative disease
27 CT developers secure $180M construction loan for new life science facility
28 Arvinas Announces Upcoming Presentations at the American
29 Heavyweight Division: Arvinas Paves the Way for Therapeutics That Degrade Disease-Related Proteins
30 Arvinas: Tremendous Value Increase With Pfizer Mega-Deal, High Potential
31 Arvinas Reports Fourth Quarter and Full Year 2020 Financial
32 Connecticut's 'Innovation Corridors' slated to create 15K jobs. Here's how it will work.
33 Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
34 I made the official 'Ted Lasso' biscuit recipe, and they were a delicious watch-party snack
35 Penn Badgley says he had an 'out-of-body experience' while filming his final line for 'Gossip Girl'
36 Arvinas Releases Interim Clinical Data Further Demonstrating the Powerful Potential of PROTAC® Protein Degraders ARV-471
37 FIFA says it's 'deeply concerned' by images of the Congolese Under-20 women's team training in the middle of a busy dirt road
38 Dan Bongino is threatening to quit his talk show over the radio network's vaccine mandate
39 News Flash: Analysts Just Made A Huge Upgrade To Their Arvinas, Inc. (NASDAQ:ARVN) Forecasts
40 Pfizer and Arvinas announce $1bn deal for investigational oral protein degrader
41 Hedge Funds Are Dumping Arvinas, Inc. (ARVN)
42 Connecting The Dots: Are Pfizer And Arvinas At Work On A COVID Cure?
43 Neurona Therapeutics Appoints Brad Margus to its Board of Directors
44 Should You Keep on Holding Your Facebook (FB) Position?
45 Shareholders Are Thrilled That The Arvinas (NASDAQ:ARVN) Share Price Increased 160%
46 Have Arvinas, Inc. (NASDAQ:ARVN) Insiders Been Selling Their Stock?
47 11 Best Value Stocks To Buy According To Warren Buffett
48 The Top 25 Women Leaders in Biotechnology of 2021
49 Bradley Margus Is The Independent Director of Arvinas, Inc. (NASDAQ:ARVN) And They Just Sold 33% Of Their Shares
50 Edie Falco says acting with James Gandolfini on 'The Sopranos' was like 'two kids playing in the sandbox'
51 11 Best Robinhood Stocks To Buy According To Hedge Funds
52 10 Best Stocks Under $10 According to Billionaire Daniel Och’s OZ Management
53 PROteolysis Targeting Chimera (PROTAC) Market : Global Development Trends and Analysis 2021-2027 | Arvinas, Merck, Kymera, Pfizer, AstraZeneca – The Manomet Current
54 The CHAMP? Ranok raises $40M to show it can knockout other protein degrader technologies
55 Arvinas: Leading In Cutting Edge Protein Degrader Development
56 Thinking about trading options or stock in Snap, Twitter, Trade Desk, Arvinas, or Intel Corp?
57 Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market To Make Huge Impact In Near Future Basic Influencing Factors Driving The Industry 2021–2028 – IMIESA
58 The search for a better Faslodex continues
59 Global Metastatic Prostate Cancer Treatment Market By Top Key Players Like , By Market Players:, AB Science etc. – Puck77
60 What's Next For Arvinas After A Solid 2x Increase?
61 Arvinas Announces Pipeline Programs Targeting Validated and
62 Former officer and NASA exec found guilty of murdering neighbor after years of disputes over loud music and dog poop
63 ARVN Stock: How Tackling The 'Undruggable' Could Reap Billions In Sales
64 PAQ Therapeutics emerges with $30M series A for autophagy-based treatments
65 Global Metastatic Breast Cancer Pipeline Insight Report 2021: Focus on 100+ Companies and 100+ Pipeline Drugs
66 Arvinas to Present at the 42nd Annual Goldman Sachs Global
67 Stocks making the biggest moves midday: DoorDash, Airbnb, Denny's, Virgin Galactic, Arvinas & more
68 Here's Why Arvinas Shares Are Tumbling 13.7% Today
69 Bayer and Arvinas Join Forces in $115M Pharma & Ag Research Alliance
70 Lilly doubles down on protein degradation, inking $35M deal with Lycia and promising $1.6B more
71 Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion
72 Arvinas in $830M-plus Pfizer biobucks deal
73 Arvinas to Hold Virtual 2020 Annual Meeting of Stockholders
74 Genentech doubles down on Arvinas, swelling deal to $650M
75 Bayer beefs up discovery work with Vividion buyout
76 Arvinas lines up for $100M IPO | FierceBiotech
77 Bayer and Arvinas Unveil Targeted Protein Degradation Joint
78 Arvinas to Present at the 2020 Wedbush PacGrow Virtual Healthcare Conference
79 Pfizer bets $1B cash on the original protein degraders as technology nears prime time
80 CBRE Arranges $180M Construction Loan for Life Sciences Development in New Haven, Connecticut
81 Arvinas Reports Fourth Quarter and Full Year 2019 Financial
82 Lin Wood is trying to claw back the $2 million he raised for Kyle Rittenhouse's bail
83 Wall Street stuck on Monte Rosa; glue pot could be deep in protein degradation
84 Governor Lamont Announces Launch of Online Hub Highlighting the Benefits for Young Professionals To Live and Work in Connecticut
85 New Haven's Arvinas Raises $55M To Begin Cancer Trials
86 Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
87 ARV-110 for Prostate Cancer Shows Promise in Heavily Treated Patients
88 Arvinas Receives Fast Track Designation for its Targeted Protein Degrader ARV-110 as a Treatment for
89 Arvinas Releases Updated Dose Escalation Data from Clinical Trial of PROTAC® Protein Degrader ARV-110 in
90 Arvinas Strengthens Management Team with Internal Appointments of Andy Crew, Ph.D. as Chief Technology Officer
91 Arvinas Appoints Wendy Dixon, Ph.D., to its Board of Directors
92 Arvinas to Present at the 31st Annual Piper Jaffray Healthcare Conference
93 Arvinas to Present Initial Data from Ongoing Clinical Trials and a Pipeline Update at the 2nd
94 Arvinas Reports Second Quarter 2019 Financial Results and
95 Pfizer and Arvinas sign $830M drug development deal that target proteins causing disease
96 Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs
97 Merck wagers $434M on Arvinas and its protein-disposal system
98 Why Oerth Bio CEO is ready to challenge $60B crop protection market
99 Arvinas Appoints Laurie Smaldone Alsup, MD, to Board of
100 CBRE arranges $180 million construction loan for life sciences development at 101 College St., New Haven, CT